TAU researcher harnesses targeted delivery of microRNAs to primary tumors in mice to block the movement of cancer
A new Tel Aviv University study finds that combining genetic therapy with…
Cleveland Clinic and The Hebrew University of Jerusalem to Develop Global Center for Transformative Nanomedicine
Cleveland Clinic and The Hebrew University of Jerusalem will begin a formal…
UNESCO: Scientific Advisory Board to share recommendations with UN Secretary General in New York
UN Secretary General Ban Ki-moon will meet with his Scientific Advisory Board,…
France-Israel: 4P-Pharma, SATT Aquitaine and Bordeaux University to develop an anti-cancer drug. Video
4P-Pharma has signed an exclusive license agreement with Aquitaine Science Transfert, for…
Big data: Bank Hapoalim and the Technion agree to enhance Data Science cooperation
Bank Hapoalim CEO Arik Pinto and Peretz Lavie, president of the Technion…
TAU (Israel): The dual effect of a ferredoxin-hydrogenase fusion protein in vivo: successful divergence of the photosynthetic electron flux towards hydrogen production and elevated oxygen tolerance
Hydrogen photo-production in green algae, catalyzed by the enzyme [FeFe]-hydrogenase (HydA), is…
Israel: Rapid Medical’s Comaneci Adjustable Remodeling Mesh Exceeds 500 Successful Aneurysm Treatments
Rapid Medical, a company focused on the development of neurovascular interventional devices,…
IBM Alpha Zone accelerator in Israel
IBM Alpha Zone accelerator offers a 20 week professional and deep immersion…
